Industry and the Well-being of the Poor

Antibiotics are hailed as life-savers and miracle drugs. Then, why would pharmaceutical companies back out from the production of new antibiotics? Professor Mukesh Eswaran says they are doing so because they are spending their money on more profitable drugs such as lifestyle drugs. Using his research, Professor Mukesh Eswaran sheds light on this issue and related issues of profitability and alleviation of poverty.

Professor Mukesh Eswaran, Full Professor, Vancouver School of Economics, The University of British Columbia.

Scroll To Top